[go: up one dir, main page]

CO5770112A1 - Secretasa de la enfermedad de alzheimer, substratos de la app y sus usos - Google Patents

Secretasa de la enfermedad de alzheimer, substratos de la app y sus usos

Info

Publication number
CO5770112A1
CO5770112A1 CO00072196A CO00072196A CO5770112A1 CO 5770112 A1 CO5770112 A1 CO 5770112A1 CO 00072196 A CO00072196 A CO 00072196A CO 00072196 A CO00072196 A CO 00072196A CO 5770112 A1 CO5770112 A1 CO 5770112A1
Authority
CO
Colombia
Prior art keywords
app
secretase
alzheimer
substrates
disease
Prior art date
Application number
CO00072196A
Other languages
English (en)
Inventor
Mark E Gurney
Michael S Bienkowski
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US09/416,901 external-priority patent/US6699671B1/en
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CO5770112A1 publication Critical patent/CO5770112A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/48—Hydrolases (3) acting on peptide bonds (3.4)
    • C12N9/50—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25)
    • C12N9/64—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue
    • C12N9/6421—Proteinases, e.g. Endopeptidases (3.4.21-3.4.25) derived from animal tissue from mammals
    • C12N9/6478—Aspartic endopeptidases (3.4.23)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid
    • C12N2799/026—Uses of viruses as vector for the expression of a heterologous nucleic acid where the vector is derived from a baculovirus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/948—Hydrolases (3) acting on peptide bonds (3.4)
    • G01N2333/95—Proteinases, i.e. endopeptidases (3.4.21-3.4.99)
    • G01N2333/964—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue
    • G01N2333/96425—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals
    • G01N2333/96427—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general
    • G01N2333/9643—Proteinases, i.e. endopeptidases (3.4.21-3.4.99) derived from animal tissue from mammals in general with EC number
    • G01N2333/96472—Aspartic endopeptidases (3.4.23)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Neurology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

? Un método para ensayar la actividad de a-secretasa de hu-Asp1 y que comprende los siguientes pasos: (a) El contacto entre la proteína hu-Asp1 y un substrato de proteína precursora de amiloide (APP), en donde dicho substrato contiene un sitio de escisión de a-secretasa; y (b) Determinar la escisión del substrato APP en el sitio de escisión a, y así ensayar la actividad de a -secretasa de hu-Asp1.
CO00072196A 1999-09-23 2000-09-22 Secretasa de la enfermedad de alzheimer, substratos de la app y sus usos CO5770112A1 (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US15549399P 1999-09-23 1999-09-23
US09/416,901 US6699671B1 (en) 1998-09-24 1999-10-13 Alzheimer's disease secretase, APP substrates therefor, and uses therefor
US16923299P 1999-12-06 1999-12-06

Publications (1)

Publication Number Publication Date
CO5770112A1 true CO5770112A1 (es) 2007-06-29

Family

ID=34753605

Family Applications (1)

Application Number Title Priority Date Filing Date
CO00072196A CO5770112A1 (es) 1999-09-23 2000-09-22 Secretasa de la enfermedad de alzheimer, substratos de la app y sus usos

Country Status (12)

Country Link
EP (1) EP1224297B1 (es)
AR (1) AR025754A1 (es)
AT (1) ATE431419T1 (es)
AU (1) AU782312B2 (es)
CA (1) CA2397786A1 (es)
CO (1) CO5770112A1 (es)
DK (1) DK1224297T3 (es)
ES (1) ES2327312T3 (es)
PE (1) PE20010693A1 (es)
PT (1) PT1224297E (es)
TW (2) TWI294462B (es)
WO (1) WO2001023533A2 (es)

Families Citing this family (44)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7456007B1 (en) 1998-12-31 2008-11-25 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
US7115410B1 (en) 1999-02-10 2006-10-03 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
CA2359785A1 (en) 1999-02-10 2000-08-17 John P. Anderson .beta.-secretase enzyme compositions and methods
AU3770800A (en) 1999-03-26 2000-10-16 Amgen, Inc. Beta secretase genes and polypeptides
JP5138851B2 (ja) 1999-06-28 2013-02-06 オクラホマ メディカル リサーチ ファウンデーション 触媒的に活性な組換えメマプシンおよびその使用方法
US7514408B1 (en) 1999-12-02 2009-04-07 Elan Pharmaceuticals, Inc. β-secretase enzyme compositions and methods
CA2401749A1 (en) 2000-03-23 2001-09-27 Elan Pharmaceuticals, Inc. Compounds and methods to treat alzheimer's disease
US6713276B2 (en) 2000-06-28 2004-03-30 Scios, Inc. Modulation of Aβ levels by β-secretase BACE2
CA2410680A1 (en) 2000-06-30 2002-01-10 Elan Pharmaceuticals, Inc. Compounds to treat alzheimer's disease
US6846813B2 (en) 2000-06-30 2005-01-25 Pharmacia & Upjohn Company Compounds to treat alzheimer's disease
PE20020276A1 (es) 2000-06-30 2002-04-06 Elan Pharm Inc COMPUESTOS DE AMINA SUSTITUIDA COMO INHIBIDORES DE ß-SECRETASA PARA EL TRATAMIENTO DE ALZHEIMER
EP1666452A2 (en) 2000-06-30 2006-06-07 Elan Pharmaceuticals, Inc. Compounds to treat Alzheimer's disease
US7217556B1 (en) 2000-12-23 2007-05-15 Pfizer Inc Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in Alzheimer's disease
US7601528B1 (en) 2000-12-23 2009-10-13 Elan Pharmaceuticals, Inc. Crystallization and structure determination of glycosylated human beta secretase, an enzyme implicated in alzheimer's disease
US7806980B2 (en) 2000-12-23 2010-10-05 Elan Pharmaceuticals, Inc. Method for crystallizing human beta secretase in complex with an inhibitor
US7384773B1 (en) 2001-05-10 2008-06-10 Pfizer Inc Crystal of HIV protease-cleaved human beta secretase and method for crystallization thereof
US7524668B1 (en) 2001-05-10 2009-04-28 Elan Pharmaceuticals, Inc. Crystal of human beta secretase having monoclinic space group symmetry C2 and methods for crystallization thereof
CA2448834A1 (en) 2001-06-01 2002-12-12 Elan Pharmaceuticals, Inc. Hydroxy alkyl amine derivatives as beta-secretase inhibitors and their use for the treatment of alzheimer's disease and similar diseases
JP2004532894A (ja) 2001-06-13 2004-10-28 イーラン　ファーマスーティカルズ、インコーポレイテッド アルツハイマー病を治療するためのアミンジオール
MXPA04000140A (es) 2001-06-27 2004-06-03 Elan Pharm Inc Derivados de beta-hidroxiamina utiles en el tratamiento de enfermedad de alzheimer.
CA2453444A1 (en) 2001-07-10 2003-01-23 Elan Pharmaceuticals, Inc. Diaminediols for the treatment of alzheimer's disease
EP1404664A1 (en) 2001-07-10 2004-04-07 Elan Pharmaceuticals, Inc. Aminediols for the treatment of alzheimer's disease
JP2005503144A (ja) * 2001-07-26 2005-02-03 アステック テクノロジー リミテッド 新規ｂａｃｅタンパク質、その核酸分子、新規ｂａｃｅタンパク質の新規結晶構造、並びに製造及び使用方法
US7186539B1 (en) 2001-08-31 2007-03-06 Pharmacia & Upjohn Company Method for refolding enzymes
BR0213139A (pt) 2001-10-04 2004-08-10 Elan Pharm Inc Composto, método de tratamento ou prevenção de doenças e de preparação de um composto, uso de um composto e composição farmacêutica
JP4547152B2 (ja) 2001-10-23 2010-09-22 オクラホマ メディカル リサーチ ファウンデーション β−セクレターゼ阻害剤および使用方法
US7045311B2 (en) 2001-10-25 2006-05-16 Monogram Biosciences, Inc. Whole cell assay systems for cell surface proteases
IL161881A0 (en) 2001-11-08 2005-11-20 Upjohn Co N,N'-substituted-1,3-diamino-2-hydroxypropane derivatives
DE60327250D1 (de) 2002-02-21 2009-05-28 Pharmacia & Upjohn Co Llc Modifizierte bace
WO2004058686A1 (en) 2002-04-30 2004-07-15 Elan Pharmaceuticals, Inc. Hydroxypropyl amides for the treatment of alzheimer’s disease
US7442537B1 (en) 2002-05-10 2008-10-28 Elan Pharmaceuticals, Inc. Crystals of unliganded beta secretase and/or beta secretase-like proteins and the use thereof
JP2004000060A (ja) * 2002-05-31 2004-01-08 Otsuka Pharmaceut Co Ltd アミロイドβ産生に影響を与える化合物のスクリーニング方法
DOP2003000765A (es) 2002-11-27 2004-05-31 Elan Fharmaceuticals Inc Ureas substituidas y carbamatos utiles para el tratamiento de la enfermedad de alzheimer (substituted ureas and carbamates useful in the treatment of alzheimer`s disease
CA2523232A1 (en) 2003-04-21 2004-11-04 Elan Pharmaceuticals, Inc. (hetero) arylamide 2-hydroxy-3-diaminoalkanes for use in the treatment of alzheimer's disease
WO2004099402A1 (en) 2003-05-02 2004-11-18 Elan Pharmaceuticals, Inc. Glycosylation variants of bace
WO2005087751A2 (en) 2004-03-09 2005-09-22 Elan Pharmaceuticals, Inc. Substituted hydroxyethylamine aspartyl protease inhibitors
JP2008505930A (ja) 2004-07-09 2008-02-28 エラン ファーマシューティカルズ，インコーポレイテッド オキシム誘導体置換ヒドロキシエチルアミン系のアスパラギン酸プロテアーゼ阻害薬
US7906625B2 (en) 2005-01-24 2011-03-15 Amgen Inc. Humanized anti-amyloid antibody
WO2007047305A1 (en) 2005-10-12 2007-04-26 Elan Pharmaceuticals, Inc. Methods of treating amyloidosis using cyclopropyl derivative aspartyl protease inhibitors
TW200815349A (en) 2006-06-22 2008-04-01 Astrazeneca Ab New compounds
CA2687750C (en) 2007-07-06 2016-10-18 Boehringer Ingelheim International Gmbh Substituted amino-quinazolinones, medicaments comprising said compound, their use and their method of manufacture
TW201020244A (en) 2008-11-14 2010-06-01 Astrazeneca Ab New compounds
EP2281824A1 (en) 2009-08-07 2011-02-09 Noscira, S.A. Furan-imidazolone derivatives, for the treatment of cognitive, neurodegenerative or neuronal diseases or disorders
EP2643299B1 (en) 2010-11-22 2016-06-22 Noscira, S.A. Bipyridine sulfonamide derivatives for the treatment of neurodegenerative diseases or conditions

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH09178743A (ja) * 1995-12-27 1997-07-11 Oriental Yeast Co Ltd 可溶性ａｐｐの定量法
EP0848062A3 (en) * 1996-12-14 2000-07-05 Smithkline Beecham Corporation Aspartic protease ASP1
AU1726199A (en) * 1997-12-31 1999-07-19 Chiron Corporation Metastatic cancer regulated gene
KR20060111905A (ko) * 1998-09-24 2006-10-30 파마시아 앤드 업존 캄파니 엘엘씨 알츠하이머병 세크레타제

Also Published As

Publication number Publication date
CA2397786A1 (en) 2001-04-05
WO2001023533A3 (en) 2002-05-10
EP1224297A2 (en) 2002-07-24
AU7607100A (en) 2001-04-30
TWI294462B (en) 2008-03-11
EP1224297B1 (en) 2009-05-13
DK1224297T3 (da) 2009-09-07
TW200745552A (en) 2007-12-16
AU782312B2 (en) 2005-07-21
WO2001023533A2 (en) 2001-04-05
PE20010693A1 (es) 2001-06-24
ES2327312T3 (es) 2009-10-28
ATE431419T1 (de) 2009-05-15
PT1224297E (pt) 2009-08-17
AR025754A1 (es) 2002-12-11

Similar Documents

Publication Publication Date Title
CO5770112A1 (es) Secretasa de la enfermedad de alzheimer, substratos de la app y sus usos
DE69941429D1 (de) 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a
AR027073A1 (es) Ensayos y metodos de diagnostico y tratamiento basados en el uso de canales de sodio como objetivos de amiloide beta o de sus agregados
ES2145318T3 (es) Imidazo(4,5-c)quinolin-aminas.
BR9507912A (pt) Combinações de inbidores de protease retroviral
DE60109802D1 (de) Annulusreparatursystem
ES2185712T3 (es) Procedimientos y equipos de analisis para el diagnostico especifico y sensible de las enfermedades periodontales.
ES2055587T3 (es) El uso de agonistas selectivos de gaba-b como agentes antitusivos.
BR0009919B1 (pt) sistema de teste para a verificaÇço de um poÇo de sondagem, e mÉtodo de verificaÇço de um poÇo.
DE69930335D1 (de) Vorrichtung für die Chirurgie der Hornhaut
ES2061459T3 (es) Procedimiento de ensayo de substancias fisiologicamente activas.
DE60026778D1 (de) Substrat für lichtemittierende Vorrichtung, lichtemittierende Vorrichtung und Herstellungsverfahren
ES2148125T1 (es) Procedimiento de regulacion de la desinfeccion de liquidos.
ES2175453T3 (es) Procedimiento de diagnostico para la alterosclerosis.
AR037870A1 (es) Metodo para determinar la actividad biologica de defibrotida
DK1353948T3 (da) Oplöselige biologiske analoge til bata-amyloidpeptid
ITPI20000027A0 (it) Metodo ed apparecchiatura per apertura, posizionamento e caricamento su forme di calzini, gambaletti e simili.
BR0011801A (pt) Inibidores de benzamida substituìda para 3c protease de rinovìrus
PT1147420E (pt) Inibidor de tripsina urinario para o diagnostico da sida
ES2157332T3 (es) Procedimiento que indica la neutralizacion de las soluciones que desinfectan las lentes de contacto.
AR027327A1 (es) Procedimiento para la separacion einzimatica de racematos de derivados de aminometil-aril-ciclohezanol
NO880094D0 (no) Ventilanordning for undersjoeisk produksjonstesting.
ATE326982T1 (de) Testsystem zur evaluierung der kompatibilität biologisch aktiver substanzen mit copolymeren
EP1270736A4 (en) FILMS FOR ASSAYING PROTEASE ACTIVITY
ITPI20010054A0 (it) Metodo e apparecchiatura per caricamento su forme di calzini, gambaletti e simili

Legal Events

Date Code Title Description
FC Application refused